175204-45-2 Usage
Uses
Given the limited information available in the provided materials, the specific applications of 4-(Bromomethyl)-2,6-Dichloropyridine are not explicitly detailed. However, based on its chemical structure and the general uses of pyridine derivatives, potential applications may include:
Used in Pharmaceutical Industry:
4-(Bromomethyl)-2,6-Dichloropyridine could be used as an intermediate in the synthesis of various pharmaceutical compounds, given the versatility of the pyridine ring in drug design. Its bromomethyl and dichloro substituents may allow for further chemical reactions to produce bioactive molecules.
Used in Chemical Synthesis:
In the chemical industry, 4-(Bromomethyl)-2,6-Dichloropyridine might serve as a building block for the creation of more complex molecules, such as agrochemicals, dyes, or other specialty chemicals, where the pyridine core is a common structural element.
Check Digit Verification of cas no
The CAS Registry Mumber 175204-45-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,2,0 and 4 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 175204-45:
(8*1)+(7*7)+(6*5)+(5*2)+(4*0)+(3*4)+(2*4)+(1*5)=122
122 % 10 = 2
So 175204-45-2 is a valid CAS Registry Number.
InChI:InChI=1/C6H4BrCl2N/c7-3-4-1-5(8)10-6(9)2-4/h1-2H,3H2
175204-45-2Relevant academic research and scientific papers
POTASSIUM CHANNEL MODULATORS
-
Paragraph 0193; 0195, (2018/01/14)
Provided are novel compounds of Formula (I): and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions, associated with potassium channels. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with potassium channels.
Lactam metalloprotease inhibitors
-
, (2008/06/13)
The present application describes novel lactams and derivatives thereof of formula I: or pharmaceutically acceptable salt forms thereof, wherein rings ring B is a 4-8 membered cyclic amide containing from 0-3 additional heteroatoms selected from N, O, and S, which are useful as metalloprotease inhibitors.
